Strategic project design to maximize success
Decrease time to fusion and drive high affinity immune response
Wide array of screening options to refine clone selection
Stabilize cell lines for consistent production
Move seamlessly into cGMP Antibody Production
Search All Human Hormones Biomarkers
Infectious Disease Veterinary Controls/Secondary Abs
Monoclonal Antibodies to Chikungunya Virus

MBS is pleased to announce that 3 monoclonal antibodies specific to Chikungunya virus (CHIKV) are purified and ready for sampling.  MAB243P, MAB244P and MAB245P were developed in close partnership with […]

New Norovirus Antibody Added to Comprehensive Panel of Diagnostic Antibodies

Portland, Maine – MBS has added a new norovirus antibody to a diagnostic panel that now includes seven monoclonal antibodies.  MAB242P, the most recently developed antibody, is the first MBS […]

MBS Collaborator in the News – Ralph Baric on Controversial Research Policy

How A Tilt Toward Safety Stopped A Scientist’s Virus Research As cases of a worrisome respiratory virus continue to pop up in the Middle East, scientists who study it in […]

Maine Biotechnology Services is a premier provider of antibody services, from design and development to production and characterization. MBS extends the creativity and experience necessary for more complex hybridoma development projects, including small molecules and anti-idiotypic.  MBS’s development tools and expertise benefit not only service customers but also product customers as these tools are applied in the internal development of new antibody products.  MBS was founded in 1990 by Dr. Joseph Chandler and continues to be wholly owned and operated in Maine.

Browse our site to learn more about our antibody experience and capabilities.